Sudip Bandopadhyay, Market Expert told CNBC-TV18, "I think the uncertainty regarding many of these pharma companies still persists. Having said that, some good buying opportunities are available. However you have to be extremely careful because the USFDA related issues are serious and to an extent unpredictable. So, you have to pick up stocks which have limited exposure to these matters."
"We are bullish on Natco Pharma for some time and we have been advising investors on Natco Pharma. We believe that the stock has also corrected along with other pharma stocks. So, it is a good buying opportunity in Natco Pharma as things stand today," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
